Prognostic Genes in the Tumor Microenvironment in Cervical Squamous Cell Carcinoma

Overview

Journal Aging (Albany NY)

Specialty Geriatrics

Date 2019 Nov 20

PMID 31740624

Citations 27

Authors

Xin-Bin Pan

Yan Lu

Jian-Li Huang

Ying Long

De-Sheng Yao

Affiliations

Soon will be listed here.

Abstract

Cervical squamous cell carcinoma (CSCC) is one of the most commonly occurring gynecological malignancies. Because CSCC is a biologically heterogeneous disease, its prognosis varies. Therefore, identifying prognostic biomarkers that reflect its biological heterogeneity could lead to better interventions for patients with a poor prognosis. This study used the ESTIMATE algorithm to identify immune related prognostic genes within the tumor microenvironment of CSCC. The results revealed that high immune scores were associated with better overall survival (P = 0.029). Differential expression analysis revealed 384 intersection genes influencing both the immune and stromal scores. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses showed the 384 intersection genes to be mainly enriched for T cell activation, the region of the membrane, carbohydrate binding, and cytokine-cytokine receptor interaction. Among them, 149 immune genes were predictive of overall survival in CSCC. These findings provide a more comprehensive understanding of immune genes within the tumor microenvironment as well as a list of immune genes prognostic in CSCC.

Citing Articles

Tian W, Tan S, Wang J, Shen P, Qin Q, Zi D Discov Oncol. 2024; 15(1):119.

PMID: 38615287 PMC: 11016529. DOI: 10.1007/s12672-024-00979-1.

Integration of genomics and transcriptomics highlights the crucial role of chromosome 5 open reading frame 34 in various human malignancies.

Li Y, Zhang Y, Sun D, Zhang X, Long S, Feng J Aging (Albany NY). 2023; 15(23):14384-14410.

PMID: 38078888 PMC: 10756085. DOI: 10.18632/aging.205310.

Computational image features of immune architecture is associated with clinical benefit and survival in gynecological cancers across treatment modalities.

Azarianpour S, Corredor G, Bera K, Leo P, Fu P, Toro P J Immunother Cancer. 2022; 10(2).

PMID: 35115363 PMC: 8814810. DOI: 10.1136/jitc-2021-003833.

Identification and Validation of Immune-Related Prognostic Genes in the Tumor Microenvironment of Colon Adenocarcinoma.

Pan S, Tang T, Wu Y, Zhang L, Song Z, Yu S Front Genet. 2022; 12:778153.

PMID: 35047006 PMC: 8762242. DOI: 10.3389/fgene.2021.778153.

mA regulator-mediated methylation modification patterns and tumor immune microenvironment in sarcoma.

Li Z, Wei J, Zheng H, Gan X, Song M, Zhang Y Aging (Albany NY). 2022; 14(1):330-353.

PMID: 34979500 PMC: 8791212. DOI: 10.18632/aging.203807.

References

Gupta S, Maheshwari A, Parab P, Mahantshetty U, Hawaldar R, Sastri Chopra S . Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial. J Clin Oncol. 2018; 36(16):1548-1555. DOI: 10.1200/JCO.2017.75.9985. View

Milioli H, Tishchenko I, Riveros C, Berretta R, Moscato P . Basal-like breast cancer: molecular profiles, clinical features and survival outcomes. BMC Med Genomics. 2017; 10(1):19. PMC: 5370447. DOI: 10.1186/s12920-017-0250-9. View

Kung C, Pingel J, Heikinheimo M, Klemola T, Varkila K, Yoo L . Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat Med. 2000; 6(3):343-5. DOI: 10.1038/73208. View

Melan K, Janky E, Macni J, Ulric-Gervaise S, Dorival M, Veronique-Baudin J . Epidemiology and survival of cervical cancer in the French West-Indies: data from the Martinique Cancer Registry (2002-2011). Glob Health Action. 2017; 10(1):1337341. PMC: 5496169. DOI: 10.1080/16549716.2017.1337341. View

Ravishankar Ram M, Goh K, Leow A, Poh B, Loke M, Harrison R . Polymorphisms at Locus 4p14 of Toll-Like Receptors TLR-1 and TLR-10 Confer Susceptibility to Gastric Carcinoma in Helicobacter pylori Infection. PLoS One. 2015; 10(11):e0141865. PMC: 4641589. DOI: 10.1371/journal.pone.0141865. View

Liu Y, Ni L, Wang S, Lv Q, Chen W, Ying S . Outcome and prognostic factors in cervical cancer patients treated with surgery and concurrent chemoradiotherapy: a retrospective study. World J Surg Oncol. 2018; 16(1):18. PMC: 5789695. DOI: 10.1186/s12957-017-1307-0. View

Gupta V, Pratap A, Singh R, Kumari R, Kumar S, Aggarwal A . Association of ITGAM, TNFSF4, TNFAIP3 and STAT4 gene polymorphisms with risk of systemic lupus erythematosus in a North Indian population. Lupus. 2018; 27(12):1973-1979. DOI: 10.1177/0961203318786432. View

von Mering C, Jensen L, Snel B, Hooper S, Krupp M, Foglierini M . STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res. 2004; 33(Database issue):D433-7. PMC: 539959. DOI: 10.1093/nar/gki005. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30. DOI: 10.3322/caac.21442. View

10.

Roberts J, Buckley R, Luo B, Pei J, Lapidus A, Peri S . CD45-deficient severe combined immunodeficiency caused by uniparental disomy. Proc Natl Acad Sci U S A. 2012; 109(26):10456-61. PMC: 3387083. DOI: 10.1073/pnas.1202249109. View

11.

Winslow S, Lindquist K, Edsjo A, Larsson C . The expression pattern of matrix-producing tumor stroma is of prognostic importance in breast cancer. BMC Cancer. 2016; 16(1):841. PMC: 5095990. DOI: 10.1186/s12885-016-2864-2. View

12.

Tas F, Erturk K . Tumor Infiltrating Lymphocytes (TILs) May be Only an Independent Predictor of Nodal Involvement but not for Recurrence and Survival in Cutaneous Melanoma Patients. Cancer Invest. 2017; 35(8):501-505. DOI: 10.1080/07357907.2017.1351984. View

13.

Luo Y, Jiang Q, Wu J, Qiu J, Zhang W, Mei X . Regulation of migration and invasion by Toll-like receptor-9 signaling network in prostate cancer. Oncotarget. 2015; 6(26):22564-74. PMC: 4673182. DOI: 10.18632/oncotarget.4197. View

14.

Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

15.

El-Omar E, Ng M, Hold G . Polymorphisms in Toll-like receptor genes and risk of cancer. Oncogene. 2008; 27(2):244-52. DOI: 10.1038/sj.onc.1210912. View

16.

Al-Harras M, Houssen M, Shaker M, Farag K, Farouk O, Monir R . Polymorphisms of glutathione S-transferase π 1 and toll-like receptors 2 and 9: Association with breast cancer susceptibility. Oncol Lett. 2016; 11(3):2182-2188. PMC: 4774482. DOI: 10.3892/ol.2016.4159. View

17.

Abou El Hassan M, Huang K, Eswara M, Zhao M, Song L, Yu T . Cancer Cells Hijack PRC2 to Modify Multiple Cytokine Pathways. PLoS One. 2015; 10(6):e0126466. PMC: 4450877. DOI: 10.1371/journal.pone.0126466. View

18.

Hom G, Graham R, Modrek B, Taylor K, Ortmann W, Garnier S . Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med. 2008; 358(9):900-9. DOI: 10.1056/NEJMoa0707865. View

19.

Camp R, Dolled-Filhart M, Rimm D . X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004; 10(21):7252-9. DOI: 10.1158/1078-0432.CCR-04-0713. View

20.

Punt S, Corver W, van der Zeeuw S, Kielbasa S, Osse E, Buermans H . Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival. Oncotarget. 2015; 6(36):38681-94. PMC: 4770729. DOI: 10.18632/oncotarget.4526. View